Archives

  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • br Liu R Li J Teng Z Zhang Z Xu

    2020-08-14


    22. Liu R, Li J, Teng Z, Zhang Z, Xu Y: Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 Vincristine by down-regulating N-Myc downstream regulated gene 1 (NDRG1). PLoS One 2013, 8:e68982
    23. Costello LC, Franklin RB: A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch Biochem Biophys 2016, 611:100e112
    25. Kajdacsy-Balla A, Geynisman JM, Macias V, Setty S, Nanaji NM, Berman JJ, Dobbin K, Melamed J, Kong X, Bosland M, Orenstein J, Bayerl J, Becich MJ, Dhir R, Datta MW: Practical aspects of plan-ning, building, and interpreting tissue microarrays: the cooperative prostate cancer tissue resource experience. J Mol Histol 2007, 38: 113e121
    26. Ananthanarayanan V, Deaton RJ, Amatya A, Macias V, Luther E, Kajdacsy-Balla A, Gann PH: Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays. Hum Pathol 2011, 42:873e881
    The American Journal of Pathology - ajp.amjpathol.org 921
    Baumann et al
    28. Guo CC, Epstein JI: Intraductal carcinoma of the prostate on needle
    29. Gautier L, Cope L, Bolstad BM, Irizarry RA: Affy–analysis of Affymetrix Genechip data at the probe level. Bioinformatics 2004, 20:307e315
    30. Bolstad BM, Collin F, Brettschneider J, Simpson K, Cope L, Irizarry RA, Speed TP: Quality Assesment of Affymetrix Genechip Data. New York, Springer, 2005
    31. R Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2017 32. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102:15545e15550
    33. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27:91e105
    34. Wong N, Wang X: MiRDB: an online resource for MicroRNA target prediction and functional annotations. Nucleic Acids Res 2015, 43: D146eD152
    35. Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, Vlachos IS, Tastsoglou S, Kanellos I, Papadimitriou D, Kavakiotis I, Maniou S, Skoufos G, Vergoulis T, Dalamagas T, Hatzigeorgiou AG: DIANA-Tarbase V8: a decade-long collection of experimentally supported Mirna-Gene interactions. Nucleic Acids Res 2018, 46:D239eD245
    37. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, Michalopoulos G, Becich M, Monzon FA: Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007, 7:64
    38. Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, Stephens RM, Caporaso NE, Loffredo CA, Ambs S: Tumor immu-nobiological differences in prostate cancer between African-American and European-American men. Cancer Res 2008, 68: 927e936
    39. Casanova-Salas I, Rubio-Briones J, Calatrava A, Mancarella C, Masia E, Casanova J, Fernandez-Serra A, Rubio L, Ramirez-Backhaus M, Arminan A, Dominguez-Escrig J, Martinez F, Garcia-Casado Z, Scotlandi K, Vicent MJ, Lopez-Guerrero JA: Identification of Mir-187 and Mir-182 as biomarkers of early diagnosis and prog-nosis in patients with prostate cancer treated with radical prostatec-tomy. J Urol 2014, 192:252e259
    41. Pollack A, Bae K, Khor LY, Al-Saleem T, Hammond ME, Venkatesan V, Byhardt RW, Asbell SO, Shipley WU, Sandler HM: The importance of protein kinase A in prostate cancer: relationship to patient outcome in radiation therapy Oncology Group Trial 92-02. Clin Cancer Res 2009, 15:5478e5484
    42. Puhr M, Hoefer J, Eigentler A, Ploner C, Handle F, Schaefer G, Kroon J, Leo A, Heidegger I, Eder I, Culig Z, Van der Pluijm G, Klocker H: The glucocorticoid receptor is a key player for prostate cancer cell survival and a target for improved antiandrogen therapy. Clin Cancer Res 2018, 24:927e938
    44. Powell IJ, Dyson G, Land S, Ruterbusch J, Bock CH, Lenk S, Herawi M, Everson R, Giroux CN, Schwartz AG, Bollig-Fischer A: Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiol Biomarkers Prev 2013, 22:891e897 
    of MicroRNAs as human prostate cancer biomarkers: a meta-analysis of related studies. J Cell Biochem 2018, 119:2763e2786
    46. Feng S, Qian X, Li H, Zhang X: Combinations of elevated tissue MiRNA-17-92 cluster expression and serum prostate-specific antigen as potential diagnostic biomarkers for prostate cancer. Oncol Lett 2017, 14:6943e6949
    47. Pashaei E, Pashaei E, Ahmady M, Ozen M, Aydin N: Meta-analysis of MiRNA expression profiles for prostate cancer recur-rence following radical prostatectomy. PLoS One 2017, 12: e0179543